Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
Bone Metastases
Brain Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
More >>
OncLive TV: Joyce A. O’Shaughnessy, MD
<< Back to Our Featured Experts
Dr. O'Shaughnessy on Role of Chemotherapy in Future TNBC Treatment
Dr. O'Shaughnessy Discusses New Developments in Molecular Profiling in Breast Cancer
Dr. O'Shaughnessy on Using Phosphoprotein Assays to Personalize Treatment for Breast Cancer
Dr. O'Shaughnessy on Adding Phosphoprotein Testing to Genomic Testing for Breast Cancer
Dr. O'Shaughnessy on Phosphoprotein Assays for Treatment Decision-Making for Breast Cancer
Dr. O'Shaughnessy on Eribulin in Metastatic Breast Cancer
Dr. O'Shaughnessy Describes the School of Breast Oncology
Dr. O'Shaughnessy on the Future of TNBC Treatment
Dr. O'Shaughnessy on the Future of Breast Cancer
Dr. O'Shaughnessy on Breast Cancer Biomarkers
Dr. O'Shaughnessy on Negative TNBC Iniparib Results
Dr. O'Shaughnessy on Avastin as Her Standard of Care
Dr. O'Shaughnessy on Continued Access to Avastin
Oncology Specialists
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Imad Tabbara, MD
Josep Tabernero, MD, PhD
Scott T. Tagawa, MD
Scott T. Tagawa, MD, MS
Julien Taieb, MD
Koichi Takahashi, MD
Mark S. Talamonti, MD
Robert L. Talley, MD
Martin S. Tallman, MD
Constantine S. Tam, MD
Winston Tan, MD
Samir Taneja, MD
Maki Tanioka, MD, PhD
Nizar M. Tannir, MD, FACP
Janos L. Tanyi, MD, PhD
William D. Tap, MD
Mary-Ellen Taplin, MD
Ahmad Tarhini, MD, PhD
Sarah K. Tasian, MD
Kurt Tauer, MD, FACP
Kurt W. Tauer, MD, FACP
Hussein A. Tawbi, MD, PhD
Alexandra Taylor, MD
Ayalew Tefferi, MD
Jennifer Temel, MD
Margaret A. Tempero, MD
Craig L. Tendler, MD
Rahul Tendulkar, MD
Masanori Terashima, MD, PhD, FACS
Welela Tereffe, MD
William P. Tew, MD
Krishnansu Tewari, MD
Premal H. Thaker, MD, MS
David D. Thiel, MD
James T. Thigpen, MD
Melanie B. Thomas, MD
Ian M. Thompson, MD
Michael A. Thompson, MD, PhD
Michael A. Thompson
Enrico Tiacci, MD
Raoul Tibes, MD, PhD
Cornelis M. van Tilburg, MD, PhD
Herve Tilly, MD, PhD
John M. Timmerman, MD
Brian A. Van Tine, MD, PhD
Vivianne Tjan-Heijnen, MD, PhD
Sara M. Tolaney, MD, MPH
Anthony W. Tolcher, MD
Kathleen Toomey, MD
Suzanne L. Topalian, MD
Max S. Topp, MD
Evanthia Roussos Torres, MD
Karim A. Touijer, MD
Danielle Townsley, MD
Edouard J. Trabulsi, MD
Edouard J. Trabulsi, MD, FACS
Tiffany A. Traina, MD
Jonathan C. Trent, MD
Jeffrey M. Trent, MD, PhD
Jonathan C. Trent, MD, PhD
Julia von Tresckow, MD
Frederic Triebel, MD, PhD
Carol Tringali, MS, RN
Debu Tripathy, MD
Domenico Trombetta, PhD
Judith Trotman, MBChB, FRACP
Judith Trotman, MD
Mark J. Truty, MD, MS
Apostolia Tsimberidou, MD, PhD
Apostolia M. Tsimberidou, MD, PhD
Nadine M. Tung, MD
Kiran K. Turaga, MD
Kiran Turaga, MD, MPH
Ismail Baris Turkbey, MD
Taylor Turner, MD
Nicholas Turner, PhD
Tim Turnham, PhD
Jonathan Tward, MD, PhD
Przemyslaw W. Twardowski, MD
Christopher Twelves, MD
Mark D. Tyson, MD
Evolving HCC Treatment Paradigm: Combinations and Sequencing
Trending Now
Novel Therapies Show Significant Activity in Relapsed/Refractory ALL
Novel Therapies Surge Forward in Relapsed/Refractory Multiple Myeloma
New BTK Agents and Combinations Are on the Horizon for B-cell Malignancies
Myriad Modalities Advance Multiple Myeloma Paradigm
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x
Subscribe